Catalyst Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-311
Closed -$257K 525
2017
Q4
$257K Hold
311
0.01% 240
2017
Q3
$147K Buy
311
+1
+0.3% +$133 0.01% 263
2017
Q2
$245K Sell
310
-13
-4% -$1.66K 0.01% 264
2017
Q1
$176K Buy
+323
New +$38.6K 0.01% 277
2016
Q3
Sell
-300
Closed -$205K 480
2016
Q2
$205K Sell
300
-110
-27% -$12.5K 0.04% 254
2016
Q1
$676K Sell
410
-430
-51% -$44.5K 0.11% 140
2015
Q4
$376K Buy
840
+750
+833% +$75.4K 0.05% 202
2015
Q3
$74K Buy
+90
New +$8.71K 0.01% 349

Other funds holding JNJ

Catalyst Capital Advisors's JNJ Position: Q2 2026 in Review

Catalyst Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 38% in Q2 2026, selling an estimated $631K and leaving 4,438 shares worth $1.13M. The position accounts for 0.02% of the portfolio, ranked #135.

Catalyst Capital Advisors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.83M in Q2 2016. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Catalyst Capital Advisors held 4,438 shares of Johnson & Johnson worth $1.13M as of Q2 2026.
  • Catalyst Capital Advisors sold 2,706 Johnson & Johnson shares in Q2 2026, an estimated $631K.
  • Johnson & Johnson made up 0.02% of Catalyst Capital Advisors's portfolio in Q2 2026, its #135 holding.
  • Catalyst Capital Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Catalyst Capital Advisors's Johnson & Johnson position peaked at $4.83M in Q2 2016.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.